earnings – cannabis.co.nz

January 20, 2022analysis, analytics, Aphria, business, Business Analysis, CANADA, canadian, cannabis, Cannin, Cannin Commentary, cbd, commentary, compliance, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, earnings, EBITDA, EU, europe, European, export, extraction, Federal, finance, financial, German, government, growing, holdings, import, industry, investing, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, product, Product Development, Q2, Quality, quarter, recreational, regulation, regulations, regulatory, report, reporting, results, retail, revenue, second, state, thc, Tilray

Is Tilray Stock a Buy Post Fiscal Q2 Results?

Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]

January 5, 2021280E, accountant, accounting, advantage, analysis, analytics, Bridge West, business, Business Analysis, C-corporation, california, Calvin Shannon, cannabis, companies, company, compliance, corp, Corporation, CPA, deduct, deductible, disadvantage, dividends, earnings, entity, expense, government, growing, industry, law, legal, legalization, legalize, legislation, liability, license, limited, marijuana, market, nondeductible, operate, partnership, product, purposes, recreational, regulation, regulations, regulatory, S-corporation, shares, state, structure, tax, taxabale, taxation, taxed, taxes, taxing, test

The Cannabis Industry and Tax Implications of Entity Structure: Issues to Consider

This piece is intended to provide some considerations that current and potential license holders should think about as they work with advisors […]